找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Recent Advances and Challenges in the Treatment of Major Depressive Disorder; Yong-Ku Kim Book 2024 The Editor(s) (if applicable) and The

[復(fù)制鏈接]
查看: 34158|回復(fù): 57
樓主
發(fā)表于 2025-3-21 17:43:11 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱Recent Advances and Challenges in the Treatment of Major Depressive Disorder
編輯Yong-Ku Kim
視頻videohttp://file.papertrans.cn/823/822583/822583.mp4
概述Provides up-to-date understanding of neurobiological mechanisms and therapeutic strategies of MDD.Describes recent advances and challenges in the treatment for MDD.Reviews pharmacotherapy, psychologic
叢書(shū)名稱Advances in Experimental Medicine and Biology
圖書(shū)封面Titlebook: Recent Advances and Challenges in the Treatment of Major Depressive Disorder;  Yong-Ku Kim Book 2024 The Editor(s) (if applicable) and The
描述.This book reviews all aspects of major depressive disorder (MDD), casting light on its neurobiological underpinnings and describing the most recent advances in management. The book is divided into four sections, the first of which discusses MDD from a network science perspective, highlighting the alterations in functional and structural connectivity and presenting insights achieved through resting state functional MRI and the development of neuroimaging-based biomarkers. The second section examines important diagnostic and neurobiological issues, while the third considers the currently available specific treatments for MDD, including biofeedback, neurofeedback, cognitive behavioral therapy, acceptance and commitment therapy, neuromodulation therapy, psychodynamic therapy, and complementary and alternative medicine. A concluding section is devoted to promising emerging treatments, from novel psychopharmacological therapies through to virtual reality treatment, immunotherapy, biomarker-guided tailored therapy, and more. Written by leading experts from across the world, the book will be an excellent source of information for both researchers and practitioners..
出版日期Book 2024
關(guān)鍵詞Antidepressant; Neuroinflammation; Pathophysiology; Depression; Ketamine
版次1
doihttps://doi.org/10.1007/978-981-97-4402-2
isbn_softcover978-981-97-4404-6
isbn_ebook978-981-97-4402-2Series ISSN 0065-2598 Series E-ISSN 2214-8019
issn_series 0065-2598
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor
The information of publication is updating

書(shū)目名稱Recent Advances and Challenges in the Treatment of Major Depressive Disorder影響因子(影響力)




書(shū)目名稱Recent Advances and Challenges in the Treatment of Major Depressive Disorder影響因子(影響力)學(xué)科排名




書(shū)目名稱Recent Advances and Challenges in the Treatment of Major Depressive Disorder網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Recent Advances and Challenges in the Treatment of Major Depressive Disorder網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Recent Advances and Challenges in the Treatment of Major Depressive Disorder被引頻次




書(shū)目名稱Recent Advances and Challenges in the Treatment of Major Depressive Disorder被引頻次學(xué)科排名




書(shū)目名稱Recent Advances and Challenges in the Treatment of Major Depressive Disorder年度引用




書(shū)目名稱Recent Advances and Challenges in the Treatment of Major Depressive Disorder年度引用學(xué)科排名




書(shū)目名稱Recent Advances and Challenges in the Treatment of Major Depressive Disorder讀者反饋




書(shū)目名稱Recent Advances and Challenges in the Treatment of Major Depressive Disorder讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:03:08 | 只看該作者
978-981-97-4404-6The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor
板凳
發(fā)表于 2025-3-22 02:16:22 | 只看該作者
Recent Advances and Challenges in the Treatment of Major Depressive Disorder978-981-97-4402-2Series ISSN 0065-2598 Series E-ISSN 2214-8019
地板
發(fā)表于 2025-3-22 05:35:54 | 只看該作者
5#
發(fā)表于 2025-3-22 10:31:04 | 只看該作者
https://doi.org/10.1007/978-981-97-4402-2Antidepressant; Neuroinflammation; Pathophysiology; Depression; Ketamine
6#
發(fā)表于 2025-3-22 15:56:22 | 只看該作者
Induce Pluripotent Stem Cells (iPSC) Technology in Depressionressive disorders (MDD). In this chapter, we explore different uses for iPSC technology, three-dimensional (3D) organoids models, and mesenchymal stem cells therapy in MDD, as well their potential and limitations.
7#
發(fā)表于 2025-3-22 19:05:10 | 只看該作者
8#
發(fā)表于 2025-3-22 22:23:57 | 只看該作者
Marie Drüge,Lisa Guthardt,Elisa Haller,Johannes Michalak,Jennifer Apolinário-Hagen
9#
發(fā)表于 2025-3-23 04:18:37 | 只看該作者
10#
發(fā)表于 2025-3-23 06:17:32 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-20 10:46
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
怀来县| 饶平县| 宁夏| 铅山县| 珠海市| 临漳县| 鄂尔多斯市| 黎城县| 永德县| 赤城县| 瑞安市| 马鞍山市| 枝江市| 哈尔滨市| 梁河县| 会泽县| 醴陵市| 霍林郭勒市| 五峰| 韶关市| 扶沟县| 东乌珠穆沁旗| 扎兰屯市| 关岭| 伊川县| 波密县| 都昌县| 邢台县| 龙游县| 油尖旺区| 岑溪市| 通化市| 淳化县| 辽源市| 玉环县| 阿克| 苏尼特左旗| 巧家县| 元朗区| 兴隆县| 图们市|